Tvardi Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TVRD and other ETFs, options, and stocks.About TVRD
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
CEOImran Alibhai
CEOImran Alibhai
Employees10
Employees10
HeadquartersSugar Land, Texas
HeadquartersSugar Land, Texas
Founded2017
Founded2017
Employees10
Employees10
TVRD Key Statistics
Market cap39.50M
Market cap39.50M
Price-Earnings ratio-0.42
Price-Earnings ratio-0.42
Dividend yield—
Dividend yield—
Average volume116.13K
Average volume116.13K
High today$4.27
High today$4.27
Low today$4.03
Low today$4.03
Open price$4.08
Open price$4.08
Volume110.87K
Volume110.87K
52 Week high$43.65
52 Week high$43.65
52 Week low$3.74
52 Week low$3.74
Stock Snapshot
As of today, Tvardi Therapeutics(TVRD) shares are valued at $4.18. The company's market cap stands at 39.5M, with a P/E ratio of -0.42.
As of 2025-12-04, Tvardi Therapeutics(TVRD) stock has fluctuated between $4.03 and $4.27. The current price stands at $4.18, placing the stock +3.7% above today's low and -2.1% off the high.
Tvardi Therapeutics(TVRD) shares are trading with a volume of 110.87K, against a daily average of 116.13K.
In the last year, Tvardi Therapeutics(TVRD) shares hit a 52-week high of $43.65 and a 52-week low of $3.74.
In the last year, Tvardi Therapeutics(TVRD) shares hit a 52-week high of $43.65 and a 52-week low of $3.74.
Analyst ratings
63%
of 8 ratingsBuy
37.5%
Hold
62.5%
Sell
0%
People also own
Based on the portfolios of people who own TVRD. This list is generated using Robinhood data, and it’s not a recommendation.